Tympanoseal Clinical Study
Part of paid clinical trials in Farmington Hills, Michigan.
- Sponsor
- Grace Medical, Inc.
- Study ID
- NCT05849844
- Status
- Recruiting
Conditions
- Tympanic Membrane Perforation
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- Tympanoseal — DEVICEAll subjects will receive the Tympanoseal device that will be placed during a surgical procedure
Study Details
The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.
Key Dates
- Start date
- Jan 5, 2024
- Status verified
- Oct 2024
- Primary completion
- Apr 20, 2026
- Completion
- Apr 20, 2026
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: TympanosealAll subjects will receive the Tympanoseal device that will be placed during a surgical procedure.
Primary Outcome Measure
Number of participants with healed tympanic membrane perforations. [ Time Frame: 12 weeks ]
Central Contacts
- Robert Stroup901-386-0990
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Michigan Ear Institute | Farmington Hills | Michigan | 48334 | Seilesh Babu, MD (PRINCIPAL_INVESTIGATOR) |
| Methodist Le Bonheur | Memphis | Tennessee | 38103 |